DIGOXIN PEDIATRIC Drug Patent Profile
When do Digoxin Pediatric patents expire, and when can generic versions of Digoxin Pediatric launch?
Digoxin Pediatric is a drug marketed by Hospira and is included in one NDA.
The generic ingredient in DIGOXIN PEDIATRIC is digoxin. There is one drug master file entry for this compound. Thirty suppliers are listed for this compound. Additional details are available on the digoxin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Digoxin Pediatric
A generic version of DIGOXIN PEDIATRIC was approved as digoxin by RISING on December 23rd, 1999.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DIGOXIN PEDIATRIC?
- What are the global sales for DIGOXIN PEDIATRIC?
- What is Average Wholesale Price for DIGOXIN PEDIATRIC?
Summary for DIGOXIN PEDIATRIC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 275 |
| DailyMed Link: | DIGOXIN PEDIATRIC at DailyMed |
Recent Clinical Trials for DIGOXIN PEDIATRIC
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Guillermo Liniado | PHASE4 |
| Hospital General de Agudos "Dr. Cosme Argerich" | PHASE4 |
| H. Lee Moffitt Cancer Center and Research Institute | PHASE2 |
US Patents and Regulatory Information for DIGOXIN PEDIATRIC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | DIGOXIN PEDIATRIC | digoxin | INJECTABLE;INJECTION | 040092-001 | Apr 25, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
